Literature DB >> 9704864

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes.

P H Pouwels1, R J Leer, M Shaw, M J Heijne den Bak-Glashouwer, F D Tielen, E Smit, B Martinez, J Jore, P L Conway.   

Abstract

In vaccination programmes in which large numbers of subjects are involved, the oral route of administration is more convenient as compared to the more frequently used parenteral route. This is particularly relevant when vaccines are to be applied in less industrialized countries. Lactic acid bacteria in general and strains of Lactobacillus in particular have a variety of properties which make them attractive candidates for oral vaccination purposes, e.g. GRAS status, adjuvant properties, mucosal adhesive properties and low intrinsic immunogenicity. An overview is given of current research aimed at unravelling the relationship between structure and properties of surface proteins of lactobacilli and in vivo colonization, in particular of species capable of adhering to epithelial cells in vitro. Secondly, the state of the art will be discussed with respect to antigen presentation by lactic acid bacteria. Finally, some preliminary immunological data of recombinant lactic acid bacterial strains expressing antigens from pathogens will be presented.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704864     DOI: 10.1016/s0168-1605(98)00048-8

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  42 in total

1.  Expression of Chlamydia psittaci- and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to bspA.

Authors:  M S Turner; P M Giffard
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Generation of food-grade recombinant lactic acid bacterium strains by site-specific recombination.

Authors:  M C Martín; J C Alonso; J E Suárez; M A Alvarez
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

3.  Display of alpha-amylase on the surface of Lactobacillus casei cells by use of the PgsA anchor protein, and production of lactic acid from starch.

Authors:  Junya Narita; Kenji Okano; Tomoe Kitao; Saori Ishida; Tomomitsu Sewaki; Moon-Hee Sung; Hideki Fukuda; Akihiko Kondo
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

4.  Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

Authors:  Karina Araujo Aires; Aurora Marques Cianciarullo; Sylvia Mendes Carneiro; Luisa Lina Villa; Enrique Boccardo; Gaspar Pérez-Martinez; Isabel Perez-Arellano; Maria Leonor Sarno Oliveira; Paulo Lee Ho
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

5.  Association of Lactobacillus spp. with Peyer's patches in mice.

Authors:  L Plant; P Conway
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment.

Authors:  S Blanquet; J P Meunier; M Minekus; S Marol-Bonnin; M Alric
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

7.  Comparative study of sugar fermentation and protein expression patterns of two Lactobacillus plantarum strains grown in three different media.

Authors:  Carme Plumed-Ferrer; Kaisa M Koistinen; Tiina L Tolonen; Satu J Lehesranta; Sirpa O Kärenlampi; Elina Mäkimattila; Vesa Joutsjoki; Vesa Virtanen; Atte von Wright
Journal:  Appl Environ Microbiol       Date:  2008-06-20       Impact factor: 4.792

8.  System using tandem repeats of the cA peptidoglycan-binding domain from Lactococcus lactis for display of both N- and C-terminal fusions on cell surfaces of lactic acid bacteria.

Authors:  Kenji Okano; Qiao Zhang; Sakurako Kimura; Junya Narita; Tsutomu Tanaka; Hideki Fukuda; Akihiko Kondo
Journal:  Appl Environ Microbiol       Date:  2007-12-21       Impact factor: 4.792

Review 9.  Enhancing oral vaccine potency by targeting intestinal M cells.

Authors:  Ali Azizi; Ashok Kumar; Francisco Diaz-Mitoma; Jiri Mestecky
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

Review 10.  Exploiting cholera vaccines as a versatile antigen delivery platform.

Authors:  Anisia J Silva; Francis O Eko; Jorge A Benitez
Journal:  Biotechnol Lett       Date:  2007-11-16       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.